Category: Newswire

UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

UCB will present 29 abstracts, including 4 late breakers, at American Epilepsy Society Annual Meeting 2023 highlighting clinical, health economic and demographic studies in epilepsy Presentations showcase diversity, potential and momentum of UCB’s epilepsy and rare syndromes portfolio, including important fenfluramine and brivaracetam data Broad data sets reveal insights into different epilepsy types and different populations… Continue reading UCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual Meeting

Neurocrine Biosciences to Host Analyst Day on December 5, 2023

SAN DIEGO, Dec. 1, 2023 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, will hold its Analyst Day focused on its R&D portfolio and strategy on Tuesday, December 5, 2023 in New York. The event will be held in-person and via webcast. It will feature Kevin Gorman, Chief Executive Officer, and… Continue reading Neurocrine Biosciences to Host Analyst Day on December 5, 2023

Vale Base Metals Chief Executive Deshnee Naidoo to Step Down

TORONTO, Dec. 1, 2023 /PRNewswire/ — Vale Base Metals Limited (VBM) today announces that Deshnee Naidoo has elected to leave the company and will step down from her position as Chief Executive Officer (CEO) of VBM effective March 31, 2024. The Board has initiated the process to identify and appoint a new CEO, who will… Continue reading Vale Base Metals Chief Executive Deshnee Naidoo to Step Down

Cloopen Announces Changes in Board Composition

BEIJING, Dec. 1, 2023 /PRNewswire/ — Cloopen Group Holding Limited (OTC: RAASY) (“Cloopen” or the “Company”) today announced changes in the composition of its board of directors (the “Board”). The Company received a letter of resignation dated November 30, 2023 from each of Mr. Changxun Sun, Mr. Yipeng Li, Mr. Xiegang Xiong, Mr. Kui Zhou… Continue reading Cloopen Announces Changes in Board Composition

Tampa General Hospital Completes Acquisition of Bravera Health and Introduces “TGH North”

TGH North Integrates Community Hospitals in Citrus and Hernando Counties with Tampa General, Extending the Reach of One of the Nation’s Leading Academic Health Systems to More Communities Across Florida. TAMPA, Fla., Dec. 1, 2023 /PRNewswire/ — Tampa General Hospital (TGH) announced today the completion of its acquisition of the Bravera Health network. The hospitals,… Continue reading Tampa General Hospital Completes Acquisition of Bravera Health and Introduces “TGH North”

Vale Base Metals Chief Executive Deshnee Naidoo to Step Down

TORONTO, Dec. 1, 2023 /PRNewswire/ – Vale Base Metals Limited (VBM) today announces that Deshnee Naidoo has elected to leave the company and will step down from her position as Chief Executive Officer (CEO) of VBM effective March 31, 2024. The Board has initiated the process to identify and appoint a new CEO, who will… Continue reading Vale Base Metals Chief Executive Deshnee Naidoo to Step Down

Nanoscope Therapeutics Announces Presentation at the FLORetina 2023 Congress

DALLAS, Dec. 1, 2023 /PRNewswire/ — Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that Francesco Bandello, MD, FEBO, will present at the 11th Annual FLORetina Congress taking place from November 30 – December 3, 2023 in Rome, Italy. Details for… Continue reading Nanoscope Therapeutics Announces Presentation at the FLORetina 2023 Congress

Blue Sky Uranium Applies to Extend Warrants

TSX Venture Exchange:   BSK Frankfurt Stock Exchange:   MAL2 OTCQB Venture Market (OTC): BKUCF VANCOUVER, BC, Dec. 1, 2023 /PRNewswire/ – Blue Sky Uranium Corp. (TSXV: BSK) (FSE: MAL2) (OTC: BKUCF), (“Blue Sky” or the “Company”) announces that it has made an application to the TSX Venture Exchange to extend the term of the outstanding warrants (the “Warrants”) as… Continue reading Blue Sky Uranium Applies to Extend Warrants

GenScript Named a BioSpace 2024 Best Place to Work

BioSpace’s “Best Places to Work” report celebrates the top 30 small and large biopharma employers across America, and demonstrates a company’s desirability in the recruitment marketplace, based on the votes and ratings of thousands of life-science community members. PISCATAWAY, N.J., Dec. 1, 2023 /PRNewswire/ — GenScript Biotech Corporation, the world’s leading provider of life-science research… Continue reading GenScript Named a BioSpace 2024 Best Place to Work